 | • レポートコード：MRC2-11QY02291 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はα1-アンチトリプシン薬のグローバル市場について調査・分析したレポートです。種類別（非経口、吸入）市場規模、用途別（ドラッグストア、病院、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別α1-アンチトリプシン薬の競争状況、市場シェア ・世界のα1-アンチトリプシン薬市場：種類別市場規模 2015年-2020年（非経口、吸入） ・世界のα1-アンチトリプシン薬市場：種類別市場規模予測 2021年-2026年（非経口、吸入） ・世界のα1-アンチトリプシン薬市場：用途別市場規模 2015年-2020年（ドラッグストア、病院、その他） ・世界のα1-アンチトリプシン薬市場：用途別市場規模予測 2021年-2026年（ドラッグストア、病院、その他） ・北米のα1-アンチトリプシン薬市場分析：米国、カナダ ・ヨーロッパのα1-アンチトリプシン薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのα1-アンチトリプシン薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のα1-アンチトリプシン薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのα1-アンチトリプシン薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter、CSL Behring、Grifols、Kamada、Abeona Therapeutics、Alnylam Pharmaceuticals、Applied Genetic Technologies Corp、Arrowhead Research Corporation、Baxalta ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Alpha-1 Antitrypsin Drugs Market
The global Alpha-1 Antitrypsin Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Alpha-1 Antitrypsin Drugs Scope and Market Size
Alpha-1 Antitrypsin Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Alpha-1 Antitrypsin Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Alpha-1 Antitrypsin Drugs market is segmented into
Parenteral
Inhalation
Segment by Application, the Alpha-1 Antitrypsin Drugs market is segmented into
Drugstore
Hospital
Others
Regional and Country-level Analysis
The Alpha-1 Antitrypsin Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Alpha-1 Antitrypsin Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Alpha-1 Antitrypsin Drugs Market Share Analysis
Alpha-1 Antitrypsin Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Alpha-1 Antitrypsin Drugs business, the date to enter into the Alpha-1 Antitrypsin Drugs market, Alpha-1 Antitrypsin Drugs product introduction, recent developments, etc.
The major vendors covered:
Baxter
CSL Behring
Grifols
Kamada
Abeona Therapeutics
Alnylam Pharmaceuticals
Applied Genetic Technologies Corp
Arrowhead Research Corporation
Baxalta
1 Study Coverage
1.1 Alpha-1 Antitrypsin Drugs Product Introduction
1.2 Market Segments
1.3 Key Alpha-1 Antitrypsin Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type
1.4.2 Parenteral
1.4.3 Inhalation
1.5 Market by Application
1.5.1 Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application
1.5.2 Drugstore
1.5.3 Hospital
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Alpha-1 Antitrypsin Drugs Market Size, Estimates and Forecasts
2.1.1 Global Alpha-1 Antitrypsin Drugs Revenue 2015-2026
2.1.2 Global Alpha-1 Antitrypsin Drugs Sales 2015-2026
2.2 Global Alpha-1 Antitrypsin Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Alpha-1 Antitrypsin Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Alpha-1 Antitrypsin Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Alpha-1 Antitrypsin Drugs Competitor Landscape by Players
3.1 Alpha-1 Antitrypsin Drugs Sales by Manufacturers
3.1.1 Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015-2020)
3.1.2 Alpha-1 Antitrypsin Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Alpha-1 Antitrypsin Drugs Revenue by Manufacturers
3.2.1 Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Alpha-1 Antitrypsin Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Alpha-1 Antitrypsin Drugs Revenue in 2019
3.2.5 Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Alpha-1 Antitrypsin Drugs Price by Manufacturers
3.4 Alpha-1 Antitrypsin Drugs Manufacturing Base Distribution, Product Types
3.4.1 Alpha-1 Antitrypsin Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Alpha-1 Antitrypsin Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Alpha-1 Antitrypsin Drugs Market Size by Type (2015-2020)
4.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020)
4.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Type (2015-2020)
4.1.3 Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Alpha-1 Antitrypsin Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Alpha-1 Antitrypsin Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Alpha-1 Antitrypsin Drugs Market Size by Application (2015-2020)
5.1.1 Global Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020)
5.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Application (2015-2020)
5.1.3 Alpha-1 Antitrypsin Drugs Price by Application (2015-2020)
5.2 Alpha-1 Antitrypsin Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Alpha-1 Antitrypsin Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Alpha-1 Antitrypsin Drugs by Country
6.1.1 North America Alpha-1 Antitrypsin Drugs Sales by Country
6.1.2 North America Alpha-1 Antitrypsin Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type
6.3 North America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Alpha-1 Antitrypsin Drugs by Country
7.1.1 Europe Alpha-1 Antitrypsin Drugs Sales by Country
7.1.2 Europe Alpha-1 Antitrypsin Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type
7.3 Europe Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Alpha-1 Antitrypsin Drugs by Region
8.1.1 Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region
8.1.2 Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type
8.3 Asia Pacific Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Alpha-1 Antitrypsin Drugs by Country
9.1.1 Latin America Alpha-1 Antitrypsin Drugs Sales by Country
9.1.2 Latin America Alpha-1 Antitrypsin Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type
9.3 Central & South America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Alpha-1 Antitrypsin Drugs by Country
10.1.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country
10.1.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Alpha-1 Antitrypsin Drugs Products Offered
11.1.5 Baxter Related Developments
11.2 CSL Behring
11.2.1 CSL Behring Corporation Information
11.2.2 CSL Behring Description and Business Overview
11.2.3 CSL Behring Sales, Revenue and Gross Margin (2015-2020)
11.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Products Offered
11.2.5 CSL Behring Related Developments
11.3 Grifols
11.3.1 Grifols Corporation Information
11.3.2 Grifols Description and Business Overview
11.3.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Grifols Alpha-1 Antitrypsin Drugs Products Offered
11.3.5 Grifols Related Developments
11.4 Kamada
11.4.1 Kamada Corporation Information
11.4.2 Kamada Description and Business Overview
11.4.3 Kamada Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Kamada Alpha-1 Antitrypsin Drugs Products Offered
11.4.5 Kamada Related Developments
11.5 Abeona Therapeutics
11.5.1 Abeona Therapeutics Corporation Information
11.5.2 Abeona Therapeutics Description and Business Overview
11.5.3 Abeona Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Products Offered
11.5.5 Abeona Therapeutics Related Developments
11.6 Alnylam Pharmaceuticals
11.6.1 Alnylam Pharmaceuticals Corporation Information
11.6.2 Alnylam Pharmaceuticals Description and Business Overview
11.6.3 Alnylam Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Products Offered
11.6.5 Alnylam Pharmaceuticals Related Developments
11.7 Applied Genetic Technologies Corp
11.7.1 Applied Genetic Technologies Corp Corporation Information
11.7.2 Applied Genetic Technologies Corp Description and Business Overview
11.7.3 Applied Genetic Technologies Corp Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Products Offered
11.7.5 Applied Genetic Technologies Corp Related Developments
11.8 Arrowhead Research Corporation
11.8.1 Arrowhead Research Corporation Corporation Information
11.8.2 Arrowhead Research Corporation Description and Business Overview
11.8.3 Arrowhead Research Corporation Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Products Offered
11.8.5 Arrowhead Research Corporation Related Developments
11.9 Baxalta
11.9.1 Baxalta Corporation Information
11.9.2 Baxalta Description and Business Overview
11.9.3 Baxalta Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Baxalta Alpha-1 Antitrypsin Drugs Products Offered
11.9.5 Baxalta Related Developments
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Description and Business Overview
11.1.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Baxter Alpha-1 Antitrypsin Drugs Products Offered
11.1.5 Baxter Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Alpha-1 Antitrypsin Drugs Market Estimates and Projections by Region
12.1.1 Global Alpha-1 Antitrypsin Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026)
12.2.2 North America: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Alpha-1 Antitrypsin Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Alpha-1 Antitrypsin Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Alpha-1 Antitrypsin Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Alpha-1 Antitrypsin Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Alpha-1 Antitrypsin Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Alpha-1 Antitrypsin Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Alpha-1 Antitrypsin Drugs Market Segments
Table 2. Ranking of Global Top Alpha-1 Antitrypsin Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Parenteral
Table 5. Major Manufacturers of Inhalation
Table 6. Global Alpha-1 Antitrypsin Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Alpha-1 Antitrypsin Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Alpha-1 Antitrypsin Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Alpha-1 Antitrypsin Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Alpha-1 Antitrypsin Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Alpha-1 Antitrypsin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Alpha-1 Antitrypsin Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alpha-1 Antitrypsin Drugs as of 2019)
Table 15. Alpha-1 Antitrypsin Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Alpha-1 Antitrypsin Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Alpha-1 Antitrypsin Drugs Price (2015-2020) (USD/Unit)
Table 18. Alpha-1 Antitrypsin Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Alpha-1 Antitrypsin Drugs Product Type
Table 20. Date of International Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Alpha-1 Antitrypsin Drugs Sales Share by Type (2015-2020)
Table 24. Global Alpha-1 Antitrypsin Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Alpha-1 Antitrypsin Drugs Revenue Share by Type (2015-2020)
Table 26. Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 27. Global Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Alpha-1 Antitrypsin Drugs Sales Share by Application (2015-2020)
Table 29. North America Alpha-1 Antitrypsin Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Alpha-1 Antitrypsin Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Alpha-1 Antitrypsin Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Alpha-1 Antitrypsin Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Alpha-1 Antitrypsin Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Alpha-1 Antitrypsin Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020)
Table 69. Baxter Corporation Information
Table 70. Baxter Description and Major Businesses
Table 71. Baxter Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Baxter Product
Table 73. Baxter Recent Development
Table 74. CSL Behring Corporation Information
Table 75. CSL Behring Description and Major Businesses
Table 76. CSL Behring Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. CSL Behring Product
Table 78. CSL Behring Recent Development
Table 79. Grifols Corporation Information
Table 80. Grifols Description and Major Businesses
Table 81. Grifols Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Grifols Product
Table 83. Grifols Recent Development
Table 84. Kamada Corporation Information
Table 85. Kamada Description and Major Businesses
Table 86. Kamada Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Kamada Product
Table 88. Kamada Recent Development
Table 89. Abeona Therapeutics Corporation Information
Table 90. Abeona Therapeutics Description and Major Businesses
Table 91. Abeona Therapeutics Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Abeona Therapeutics Product
Table 93. Abeona Therapeutics Recent Development
Table 94. Alnylam Pharmaceuticals Corporation Information
Table 95. Alnylam Pharmaceuticals Description and Major Businesses
Table 96. Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Alnylam Pharmaceuticals Product
Table 98. Alnylam Pharmaceuticals Recent Development
Table 99. Applied Genetic Technologies Corp Corporation Information
Table 100. Applied Genetic Technologies Corp Description and Major Businesses
Table 101. Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Applied Genetic Technologies Corp Product
Table 103. Applied Genetic Technologies Corp Recent Development
Table 104. Arrowhead Research Corporation Corporation Information
Table 105. Arrowhead Research Corporation Description and Major Businesses
Table 106. Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Arrowhead Research Corporation Product
Table 108. Arrowhead Research Corporation Recent Development
Table 109. Baxalta Corporation Information
Table 110. Baxalta Description and Major Businesses
Table 111. Baxalta Alpha-1 Antitrypsin Drugs Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Baxalta Product
Table 113. Baxalta Recent Development
Table 114. Global Alpha-1 Antitrypsin Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 115. Global Alpha-1 Antitrypsin Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 116. Global Alpha-1 Antitrypsin Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 117. Global Alpha-1 Antitrypsin Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 118. North America: Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 119. North America: Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 120. Europe: Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 121. Europe: Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 122. Asia Pacific: Alpha-1 Antitrypsin Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 123. Asia Pacific: Alpha-1 Antitrypsin Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 124. Latin America: Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 125. Latin America: Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 126. Middle East and Africa: Alpha-1 Antitrypsin Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 127. Middle East and Africa: Alpha-1 Antitrypsin Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Market Risks
Table 131. Main Points Interviewed from Key Alpha-1 Antitrypsin Drugs Players
Table 132. Alpha-1 Antitrypsin Drugs Customers List
Table 133. Alpha-1 Antitrypsin Drugs Distributors List
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Alpha-1 Antitrypsin Drugs Product Picture
Figure 2. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Parenteral Product Picture
Figure 4. Inhalation Product Picture
Figure 5. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Drugstore
Figure 7. Hospital
Figure 8. Others
Figure 9. Alpha-1 Antitrypsin Drugs Report Years Considered
Figure 10. Global Alpha-1 Antitrypsin Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Alpha-1 Antitrypsin Drugs Sales 2015-2026 (K Units)
Figure 12. Global Alpha-1 Antitrypsin Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2019
Figure 15. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Region in 2019
Figure 17. Global Alpha-1 Antitrypsin Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Alpha-1 Antitrypsin Drugs Revenue in 2019
Figure 19. Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Type in 2019
Figure 22. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Type in 2019
Figure 24. Global Alpha-1 Antitrypsin Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Alpha-1 Antitrypsin Drugs Sales Market Share by Application in 2019
Figure 27. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Alpha-1 Antitrypsin Drugs Revenue Market Share by Application in 2019
Figure 29. North America Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 30. North America Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2019
Figure 32. North America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.S. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Canada Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Alpha-1 Antitrypsin Drugs Market Share by Type in 2019
Figure 38. North America Alpha-1 Antitrypsin Drugs Market Share by Application in 2019
Figure 39. Europe Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 40. Europe Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2019
Figure 42. Europe Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Germany Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. France Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. U.K. Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Italy Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Russia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Alpha-1 Antitrypsin Drugs Market Share by Type in 2019
Figure 54. Europe Alpha-1 Antitrypsin Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 56. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Market Share by Region in 2019
Figure 59. China Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 60. China Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 62. Japan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 64. South Korea Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 66. India Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 68. Australia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 70. Taiwan Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 72. Indonesia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 74. Thailand Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 76. Malaysia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 78. Philippines Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 80. Vietnam Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Alpha-1 Antitrypsin Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Alpha-1 Antitrypsin Drugs Market Share by Application in 2019
Figure 83. Latin America Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 84. Latin America Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 88. Mexico Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 90. Brazil Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 92. Argentina Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Alpha-1 Antitrypsin Drugs Market Share by Type in 2019
Figure 94. Latin America Alpha-1 Antitrypsin Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 96. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 100. Turkey Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 102. Saudi Arabia Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Alpha-1 Antitrypsin Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 104. U.A.E Alpha-1 Antitrypsin Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Alpha-1 Antitrypsin Drugs Market Share by Application in 2019
Figure 107. North America Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 108. North America Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. Europe Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Asia Pacific Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Latin America Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Alpha-1 Antitrypsin Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Middle East and Africa Alpha-1 Antitrypsin Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
α放射体の世界市場（～2026年） Alpha emitters are the radioactive substances which decay after emitting the alpha particles. Alpha emitter radionuclide is considered to be a new approach to treat many cancer types. Alpha particles offers the definite tumor cell slaughter action causing the less damage to adjacent normal tissues t…- インターロイキン1アルファの世界市場（～2026年） Market Analysis and Insights: Global Interleukin 1 Alpha Market The global Interleukin 1 Alpha market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Interleukin 1 Alpha Scope and Market Size Interleukin 1 Alpha market is seg…
- 免疫療法薬の世界市場（～2026年） Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system. North America is expected to account for largest share in the …
- 吸入・点鼻薬ジェネリック医薬品の世界市場（～2026年） Inhalation and Nasal Spray is a kind of drug used to relieve sneezing, runny, stuffy, or itchy nose and itchy, watery eyes caused by hay fever or other allergies. Quality control could pose an issue in the overall growth of generic inhalers and nasal spray sales, an issue that governments are trying…
- アルファ2Cアドレナリン受容体の世界市場（～2026年） Market Analysis and Insights: Global Alpha 2C Adrenergic Receptor Market The global Alpha 2C Adrenergic Receptor market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Alpha 2C Adrenergic Receptor Scope and Market Size Alpha …